Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Analogues of BD-1008 possess functional sigma receptor antagonism and anticocaine effects

March 12, 2001

Mayo Clinic presents data on new aldehyde dehydrogenase inhibitor at ASCPT meeting

March 8, 2001

CeNeS cleared to commence clinical trial of treatment for alcohol addiction

March 2, 2001

Chelating drug to be codeveloped by Biomedical Frontiers and Chiesii

March 2, 2001

Therapeutic agents for drug addiction, withdrawal, etc., claimed by Knoll

Feb. 22, 2001

CroFab now available in the U.S. for treatment of poisonous snakebites

Feb. 1, 2001

Anticocaine catalytic MAb selectively attenuates cocaine selfadministration in rats

Jan. 9, 2001

FDA approves second indication for Antizol

Dec. 13, 2000

Antizol approved in Canada for treatment of ethylene glycol poisoning

Dec. 6, 2000

Novel, orally active iron chelator APO-363: preclinical pharmacokinetics reported at AAPS

Nov. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...